| Zugriffe | |
|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 227 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 28 | 12 | 1 | 14 | 4 | 16 | 11 |
| Zugriffe | |
|---|---|
| 2020_Belyavskiy_etal.pdf | 121 |
